Pharma company challenges the US False Claims Act: what’s at stake for whistleblowers and government enforcement? - A&O Shearman
A pharmaceutical company is currently appealing a record USD1.6 billion judgment in the US, arguing that a key part of the US False Claims Act (FCA) is unconstitutional. This case, now before the C...
Read more